Use of murine poxvirus for cancer immunotherapy and vaccines

The present invention provides a murine poxvirus vector for expressing a heterologous sequence under the control of a viral early/late promoter, and methods for their use in immunotherapy, cancer treatment, and infectious disease treatment. 本发明提供了一种用于在病毒早期/晚期启动子的控制下表达异源序列的鼠痘病毒载体,以及其用于免疫疗法、癌症治疗和传染病治疗...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SIGAL LUIS JAVIER, TANG LINJUAN, XU RENHUAN, KNUDSEN CORY
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a murine poxvirus vector for expressing a heterologous sequence under the control of a viral early/late promoter, and methods for their use in immunotherapy, cancer treatment, and infectious disease treatment. 本发明提供了一种用于在病毒早期/晚期启动子的控制下表达异源序列的鼠痘病毒载体,以及其用于免疫疗法、癌症治疗和传染病治疗的方法。